about
Ephrin-B2 ligand is a functional receptor for Hendra virus and Nipah virusInhibition of Henipavirus fusion and infection by heptad-derived peptides of the Nipah virus fusion glycoprotein.Membrane fusion tropism and heterotypic functional activities of the Nipah virus and Hendra virus envelope glycoproteins.Potent neutralization of Hendra and Nipah viruses by human monoclonal antibodies.Henipaviruses: recent observations on regulation of transcription and the nature of the cell receptor.Exceptionally potent cross-reactive neutralization of Nipah and Hendra viruses by a human monoclonal antibody.A neutralizing human monoclonal antibody protects against lethal disease in a new ferret model of acute nipah virus infection.Development of an acute and highly pathogenic nonhuman primate model of Nipah virus infection.A novel model of lethal Hendra virus infection in African green monkeys and the effectiveness of ribavirin treatmentA Hendra virus G glycoprotein subunit vaccine protects African green monkeys from Nipah virus challenge.The distribution of henipaviruses in Southeast Asia and Australasia: is Wallace's line a barrier to Nipah virus?Feline model of acute nipah virus infection and protection with a soluble glycoprotein-based subunit vaccine.Viral glycoprotein-mediated cell fusion assays using vaccinia virus vectors.Site occupancy and glycan compositional analysis of two soluble recombinant forms of the attachment glycoprotein of Hendra virus.A neutralizing human monoclonal antibody protects african green monkeys from hendra virus challengePrimary CD8+ cells from HIV-infected individuals can suppress productive infection of macrophages independent of beta-chemokinesDevelopments towards effective treatments for Nipah and Hendra virus infection.Residues in the stalk domain of the hendra virus g glycoprotein modulate conformational changes associated with receptor bindingTargeted strategies for henipavirus therapeuticsA glycosylated peptide in the West Nile virus envelope protein is immunogenic during equine infection.Functional studies of host-specific ephrin-B ligands as Henipavirus receptors.Identification of Hendra virus G glycoprotein residues that are critical for receptor binding.Receptor binding, fusion inhibition, and induction of cross-reactive neutralizing antibodies by a soluble G glycoprotein of Hendra virus.Host cell tropism mediated by Australian bat lyssavirus envelope glycoproteins.Serotype-independent detection of foot-and-mouth disease virus.Differential effects of CD28 costimulation on HIV production by CD4+ cells.CD8+ cells from asymptomatic human immunodeficiency virus-infected individuals suppress superinfection of their peripheral blood mononuclear cells.A recombinant subunit vaccine formulation protects against lethal Nipah virus challenge in cats.CD28 costimulation increases CD8+ cell suppression of HIV replication.Neutralization assays for differential henipavirus serology using Bio-Plex protein array systems.
P50
Q24532042-B36481D9-E9C3-4EEB-8FAF-B86A02149B42Q24814238-9BED8B79-F3C0-4B73-A9AA-AC450B6C92E9Q27472931-9F6FFCF8-F915-4728-BFEE-926F1B2C898FQ30805028-808310BB-3404-407A-8736-B24F2C1CBD9DQ30927135-67272F3C-101A-4BCC-A682-F69AE1A8F142Q33319628-734BECBC-8ED8-4F55-86DA-DA40A4E95AB7Q33514831-C1A970A6-8E23-48AB-AC74-C4F1EEFEF40BQ33587327-47C6B786-9F88-4221-BF3C-A367F5BDACFCQ34120677-B15CC1D8-9E1A-498B-B87D-3C6656E405DEQ34292954-4825BA84-2960-4C70-B0A7-BE91CD092983Q34700200-53C7205D-8E77-4D44-9C6C-16C172407932Q35185973-B072E28F-A5E2-4FE5-B474-63AA2217300DQ35758686-5E88A031-D475-4D7D-9194-01B572992D97Q35779475-3CD3D62A-70F0-436C-886F-73444CF6959AQ35855727-61865A93-1AFA-441B-8B5E-828714D8D6E8Q35886502-F56234DD-3A12-4ADC-B02A-312BBAB37719Q36379335-F69D33F2-1EDA-46A5-B4D4-D84AA0FC8CD3Q36949836-04D3912A-BD7D-4C6C-AC85-3113F8B5F0EFQ37175177-D713C885-659E-40C7-BF38-A5DA42C119B6Q39917059-AB327E87-1869-4C6B-A07E-FDC14492482DQ40041409-C5D0633B-A9F8-421F-B977-D951E6A70CB5Q40155851-B8A7DBD0-4A26-4F27-ABDC-EC8776083BB5Q40423310-8196CECF-A146-4A03-BB23-E65793395DEBQ42284207-6E48F395-88AD-4BFC-B9C7-6BEC6D4454FAQ43489801-B9D5683E-7120-4095-BA1C-394DEEC3F4A7Q44253774-2C8CA2A0-15F5-4A0A-AEB4-81046D04B3A6Q44631171-E139E145-A6FA-48C3-B4CC-15648C70E097Q45394416-ABC7317A-2872-422D-B799-9254F7F78C94Q46503375-0CD5BE73-F798-4BC2-83C2-9581A285AEF9Q51066972-62988417-D260-4727-B6EF-C8876A16E778
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Katharine Bossart
@ast
Katharine Bossart
@en
Katharine Bossart
@es
Katharine Bossart
@nl
Katharine Bossart
@sl
type
label
Katharine Bossart
@ast
Katharine Bossart
@en
Katharine Bossart
@es
Katharine Bossart
@nl
Katharine Bossart
@sl
prefLabel
Katharine Bossart
@ast
Katharine Bossart
@en
Katharine Bossart
@es
Katharine Bossart
@nl
Katharine Bossart
@sl
P106
P21
P31
P496
0000-0001-6886-6896